Moderna

The US is in the midst of a record-breaking bird flu outbreak that’s affected dozens of cattle herds along with poultry flocks nationwide, sending egg prices soaring

MODERNA reported a surprise third-quarter profit on Thursday (Nov 7), driven by cost cutting and higher-than-expected sales of its Covid-19 vaccine, even with low revenue from its new respiratory sync...

MODERNA on Thursday (Aug 1) cut its 2024 sales forecast for Covid-19 and respiratory syncytial virus vaccines by up to 25 per cent, or US$1 billion, due partly to low Covid sales to the EU that it exp...

Scientists are concerned that the virus will mutate and spread easily among people

MODERNA gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots.

Moderna reaffirmed its expectations for about US$4 billion in sales this year after reporting total revenue of about US$6.8 billion last year  

Moderna reported fourth-quarter revenue that beat analysts’ expectations by gaining Covid vaccine market share on its rival, Pfizer.

Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering (IPO) in the United States on Friday (Jan 5).

MODERNA shares gained nearly 14 per cent on Tuesday (Jan 2) as brokerage Oppenheimer upgraded the stock to “outperform” and the vaccine maker’s CEO reiterated the company’s goal of achieving sales gro...